SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 34 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $132,884 | -30.8% | 149,982 | +22.9% | 0.00% | – |
Q3 2022 | $192,000 | -19.3% | 122,011 | +3.0% | 0.00% | – |
Q2 2022 | $238,000 | -17.1% | 118,492 | -3.8% | 0.00% | – |
Q1 2022 | $287,000 | -51.8% | 123,193 | -3.8% | 0.00% | – |
Q4 2021 | $596,000 | -35.1% | 128,003 | +6.4% | 0.00% | – |
Q3 2021 | $919,000 | -2.4% | 120,343 | +23.8% | 0.00% | – |
Q2 2021 | $942,000 | +81.5% | 97,201 | +54.9% | 0.00% | – |
Q1 2021 | $519,000 | -27.8% | 62,738 | -40.4% | 0.00% | – |
Q4 2020 | $719,000 | -66.9% | 105,308 | -45.9% | 0.00% | -100.0% |
Q3 2020 | $2,169,000 | -80.3% | 194,514 | -88.9% | 0.00% | -75.0% |
Q2 2020 | $10,989,000 | +7226.0% | 1,749,734 | +2040.1% | 0.00% | – |
Q1 2020 | $150,000 | -52.7% | 81,758 | -12.7% | 0.00% | – |
Q4 2019 | $317,000 | +48.1% | 93,663 | -6.2% | 0.00% | – |
Q3 2019 | $214,000 | -22.7% | 99,862 | -3.8% | 0.00% | – |
Q2 2019 | $277,000 | -45.7% | 103,815 | -3.3% | 0.00% | – |
Q1 2019 | $510,000 | -91.5% | 107,388 | -92.2% | 0.00% | -100.0% |
Q3 2018 | $6,020,000 | +100233.3% | 1,368,184 | +415761.4% | 0.00% | – |
Q2 2015 | $6,000 | – | 329 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 15,001 | $1,410 | 0.00% |
KLCM Advisors, Inc. | 20,000 | $1,880 | 0.00% |
AlphaMark Advisors, LLC | 3,135 | $0 | 0.00% |
TRUST CO OF VERMONT | 204 | $19 | 0.00% |
SlateStone Wealth, LLC | 30,866 | $3 | 0.00% |
Coppell Advisory Solutions LLC | 100 | $89 | 0.00% |
Highlander Capital Management, LLC | 1,200 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Russell Investments Group, Ltd. | 266 | $25 | 0.00% |
OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,600 | $0 | 0.00% |